Cargando…

The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review

AIM: The aim of this scoping review was to determine the extent of off-patent prescription medicine use beyond registered indications in various Australian clinical settings. METHOD: The review followed the Joanna Briggs Institute approach and reported using PRISMA Extension for Scoping Reviews. Onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howe, Katrina, Bourke, Siobhan, Sansom, Lloyd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641869/ https://www.ncbi.nlm.nih.gov/pubmed/34860857 http://dx.doi.org/10.1371/journal.pone.0261022

Ejemplares similares

Incidence of unlicensed and off-label prescription in children
por: Langerová, Petra, et al.
Publicado: (2014)

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)

Patterns and predictors of off-label prescription of psychiatric drugs
por: Vijay, Aishwarya, et al.
Publicado: (2018)

Off-Label Use of Ondansetron in Pregnancy in Western Australia
por: Colvin, Lyn, et al.
Publicado: (2013)

Prevalence and factors associated with off-label antidepressant prescriptions for insomnia
por: Lai, L Leanne, et al.
Publicado: (2011)

Off-label prescriptions in intensive care unit: the Chinese experience
por: Liu, Lin, et al.
Publicado: (2018)

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
por: Zarkavelis, G., et al.
Publicado: (2022)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
por: Ebrahimi, Seyyed Reza Sadat
Publicado: (2017)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

Biologics in Dermatology: Off-Label Indications
por: Mitra, Debdeep, et al.
Publicado: (2020)

The Unlicensed and Off-Label Prescription of Medications in General Paediatric Ward: An Observational Study
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2019)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
por: Simsek, Melek, et al.
Publicado: (2019)

Profiling off-label prescriptions in cancer treatment using social health networks
por: Nikfarjam, Azadeh, et al.
Publicado: (2019)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
por: dos Santos, Laura Goedel, et al.
Publicado: (2023)

Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
por: Kouti, Leila, et al.
Publicado: (2019)

An Unappreciated Cause for the Falling off of Prescriptions
Publicado: (1916)

Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system
por: Wong, Jenna, et al.
Publicado: (2017)

Challenges in conducting paediatric trials with off-patent drugs
por: Haslund-Krog, S.S., et al.
Publicado: (2021)

Less explored off-label indications of dexmedetomidine
por: Nair, Abhijit
Publicado: (2017)

Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2022)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm)
por: Kanabar, Kewal, et al.
Publicado: (2020)

Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
por: Wilkes, Michael, et al.
Publicado: (2008)

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals – a nationwide study
por: Kimland, E, et al.
Publicado: (2012)

Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany
por: Lücke, Caroline, et al.
Publicado: (2018)

Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit
por: Vieira, Verônica Cheles, et al.
Publicado: (2021)

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
por: Fairman, Kathleen A., et al.
Publicado: (2010)

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Dynamics of price competition in Italian pharmaceutical off-patent market
por: Perna, Serena, et al.
Publicado: (2022)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012
por: Vilhelmsson, Andreas, et al.
Publicado: (2016)

Off-label drug use in children over the past decade: a scoping review
por: Tang, Yuyi, et al.
Publicado: (2023)

Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care – a nationwide study
por: Olsson, J, et al.
Publicado: (2011)

Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System
por: Gordon, Noa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eue4l9p8vfhc2cuejvahoregr6